A toxicochemical review of gallium arsenide

Defence Science Journal

Volumn 62, Issue 2, 2012, Pages 95-104

  Flora, S J S ^a   Dwivedi, Nidhi ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Biochemical effects; Gallium arsenide toxicity; Organ damage; Preventive and therapeutic measure

Indexed keywords

ARSENIC; ELECTRONIC WARFARE; GALLIUM ARSENIDE; III-V SEMICONDUCTORS; SEMICONDUCTING GALLIUM; SEMICONDUCTING GALLIUM ARSENIDE; SOLUTIONS;

'CURRENT; A: SEMICONDUCTORS; ARSENIC SPECIES; BIOCHEMICAL EFFECTS; GALLIUM ARSENIDE TOXICITY; ORGAN DAMAGE; PREVENTIVE AND THERAPEUTIC MEASURE; TOXIC EFFECT; TOXICOLOGICAL EFFECTS;

TOXICITY;

EID: 84862011793     PISSN: 0011748X     EISSN: 0976464X     Source Type: Journal    
DOI: 10.14429/dsj.62.1014     Document Type: Review

References (83)

1. Chakrabarti, A. Transition from metastability to instability in the dynamics of phase separation. Phys. Rev. B. Condens. Matter., 1992, 45(17), 9620-625.
2. Robinson, A.L. GaAs readied for high speed microcircuit. Science, 1983, 219(4582), 275-77.
3. Yamauchi, H.; Takahashi, K.; Mashiko, M. & Y amamura, Y. Biological monitoring of arsenic exposure of gallium arsenide and inorganic arsenic-exposed workers by determination of inorganic arsenic and its metabolites in urine and hair. Am. Ind. Hyg. Assoc. J., 1989, 50(11), 606-12. (Pubitemid 19269250)
4. Fowler, B.A.; Sexton, M.A. Gallium and semiconductor compounds. In Handbook on Toxicology of Metals, edited by Nordberg, G.F.; Fowler, B.A. & Nordberg, M. Academic Press, NY, USA. pp. 547-55.
5. Luster, M.I.; Portier, C.; Pait, D.G.; White, K.F.; Jennings, C.; Munson, A.E. & Rosenthal, G.J. Risk assessment in immunotoxicity I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol., 1992, 18(2), 200-10.
6. Flora, S.J. S. & Gupta, S.D. Toxicology of Gallium Arsenide: An appraisal. Def. Sci. J., 1994, 44(1), 5-10.
7. Goering, P.L.; Maronpot, R.R. & Fowler, B.A. Effect of intratracheal gallium arsenide administration on d-aminolevulinic acid dehydratase in rats: Relationship to urinary excretion of aminolevulinic acid. Toxicol. Appl. Pharmacol., 1988, 92(2), 179-93. (Pubitemid 18079207)
8. Flora, S.J. S. & Das Gupta, S. Effect of single gallium arsenide exposure on some biochemical variables in porphyrin metabolism in rats. J. Appl. Toxicol., 1992, 12(5), 333-34.
9. Flora, S.J. S.; Dube, S.N.; Vijayaraghavan, R. & Pant, S.C. Changes in certain hematological and physiological variables following single gallium arsenide exposure in rats. Biol. Trace. Elem. Res., 1997, 58(3), 197-208 (Pubitemid 27512025)
10. Flora, S.J. S.; Kannan, G.M. & Kumar, P. Selenium effects on gallium arsenide induced biochemical and immunotoxicological changes in rats. Chem. Biol. Interact., 1999, 122(1), 1-13. (Pubitemid 29354112)
11. Flora, S.J. S.; Kumar, P.; Kannan, G.M. & Rai, G.P. Acute oral gallium arsenide exposure and changes in certain hematological, hepatic, renal and immunological indices at different time intervals in male Wistar rats. Toxicology Letters, 1998, 94(2), 103-113. (Pubitemid 28180017)
12. Flora, S.J. S.; Dubey, R.; Kannan, G.M.; Chauhan, R.S.; Pant, B.P. & Jaiswal, D.K. Meso 2, 3-dimercaptosuccinic acid (DMSA) and monoisoamyl DMSA effect on gallium arsenide induced pathological liver injury in rats. Toxicology Letters, 2002, 132(1), 9-17. (Pubitemid 34655427)
13. Flora, S.J. S.; Kannan, G.M.; Pant B.P. & Jaiswal D.K. Combined administration of oxalic acid, succimer and its analogue in the reversal of gallium arsenide induced oxidative stress in rats. Arch. Toxicol., 2002, 76(5-6), 269-76. (Pubitemid 34639522)
14. Ohyama, S.; Ishinishi, N.; Hisanaga, A. & Y amamoto, A. Comparative chronic toxicity, including tumorigenicity, of gallium arsenide and arsenic trioxide intratracheally instilled into hamsters. Appl. Organometallic Chem., 1988, 2(4), 333-37.
15. Kabe, I.; Omae, K. & Nakashima, H. In vitro solubility and in vivo toxicity of indium phosphide. J. Occup. Health., 1996, 38(1), 6-12. (Pubitemid 126495384)
16. Tanaka, A.; Hisanaga, A.; Hirata, M.; Omura, M.; Makita, Y.; Inoue, N. & Ishinishi, N. Chronic toxicity of indium arsenide and indium phosphide to the lungs of hamsters. Fukuoka Igaku Zasshi., 1996, 87(5), 105-15.
17. Conner, E.A.; Y amamuchi, H.; Fowler, B.A. & Akkarman, M. Biological indicators for monitoring exposure/toxicity from III-V semiconductors. J. Exp. Anal. Environ. Epidemiol., 1993, 314(4), 431-440.
18. Conner, E.A.; Y amamuchi, H. & Fowler, B.A. Alterations in the heme biosynthetic pathway from the III-V semiconductor metal, indium arsenide (InAs). Chem. Biol. Interact., 1995, 96(3), 273-85.
19. Mast, T.J. ; Dill, J. A.; Greenspan, B.J. ; Evanoff, J. J. ; Morrissey, R.E. & Schwetz, B.A. The developmental toxicity of inhaled gallium arsenide in rodents. Teratology, 1991, 43, 455-56.
20. Omura, M.; Tanaka, A.; Hirata, M.; Zhao, M.; Makita, Y.; Inoue, N.; Gotoh, K. & Ishinishi, N. Testicular toxicity of gallium arsenide, indium arsenide, and arsenic oxide in rats by repetitive intratracheal instillation. Fundam. Appl. Toxicol., 1996, 32(1), 72-78.
21. Omura, M.; Hirata, M.; Tanaka, A.; Zhao, M.; Makita, Y.; Inoue, N.; Gotoh, K. & Ishinishi, N. Testicular toxicity evaluation of arsenic-containing binary compound semiconductors, gallium arsenide and indium arsenide in hamsters. Toxicology Letters, 1996, 89(2), 123-29. (Pubitemid 26398060)
22. Burns, L.A.; Butterworth, L.F. & Munson, A.E. Reversal of gallium arsenide-induced suppression of the antibody response by a mixed disulfide metabolite of meso 2, 3-dimercaptosuccinic acid. J. Pharmacol. Exp. Ther., 1993, 264(2), 695-700. (Pubitemid 24283529)
23. Sikorski, E.E.; Burns, L.A.; Stern, M.L.; Luster, M.I. & Munson, A.E. Splenic cell target in gallium arsenide induced suppression of the primary antibody response. Toxicol. Appl Pharmcol., 1991, 110(1), 129-42.
24. Flora, S.J. S.; Mehta, A.; Rao, P.V.L.; K annan, G.M.; Bhaskar, A.S.; Dube, S.N. & Pant, B.P. Therapeutic potential of monoisoamyl and monomethyl esters of meso 2, 3-dimercaptosuccinic acid in gallium arsenide intoxicated rats. Toxicology, 2004, 195(2-3), 127-46. (Pubitemid 38125114)
25. Timothy, A.; Lewis, G.; Hartmann, C.B.; Caffrey, R.E. & McCoy, K.L. Gallium arsenide exposure impairs splenic B cell accessory function. International Immunopharmacology, 2003, 3(3), 403-415. (Pubitemid 36293969)
26. Flora, S.J. S.; Bhatt, K. & Mehta, A. Arsenic moiety in gallium arsenide is responsible for neuronal apoptosis and behavioral alterations in rats. Am. Ind. Hyg. Assoc. J., 1987, 48(7), 660-67.
27. Yamauchi, H.; Takahashi, K. & Y amamura, Y. Metabolism and excretion of orally and intraperitoneally administered gallium arsenide in the hamster. Toxicology, 1986, 40(3), 237-46. (Pubitemid 16043799)
28. Bums, L.A.; Sikorski, E.E.; Saady, J. J. & Munson, A.E. Evidence of arsenic as the immunosuppressive component of gallium arsenide. Toxicol. Appl. Pharmacol., 1991, 110(1), 157-69.
29. Sikorski, E.E.; McCay, J. A.; White, K.L.; Bradley, S.G. & Munson, A.E. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Fund. Appl. Toxicol., 1989, 13(4), 843-58. (Pubitemid 20061139)
30. Lewis, T.A., Munson, A.E. & McCoy, K.L. Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD41 T cell activation. J. Pharmacol. Exp. Ther., 1996, 278, 1244-251. (Pubitemid 27166975)
31. Bettoulle, S.; Etienne, J. C. & Vernet, G. Acute immunotoxicity of gallium to carp (Cyprinus carpio L.) Bull. Environ. Contam. Toxicol., 2002, 68(6), 817-23. (Pubitemid 34587271)
32. Omura, M.; Y amazaki, K.; Tanaka, A.; Hirata, M.; Makita, Y. & Inoue, N. Changes in the testicular damage caused by indium arsenide and indium phosphide in hamsters during two years after intratracheal instillations. J. Occup. Health., 2000, 42(4), 196-204.
33. Flora, S.J. S. Possible health hazards associated with the use of toxic metals in semiconductor industries. J. Occup. Health., 2000, 42(3), 105-10. (Pubitemid 30431708)
34. Bhatt, K. & Flora, S.J. S. Oral co-administration of a-lipoic acid, quercetin and captopril prevents gallium arsenide toxicity in rats. Environ. Toxicol. Pharmacol., 2009, 28(1), 140-46.
35. Webb, D.R.; Sipes, I.G. & Carter, D.E. In vitro solubility and in vivo toxicity of gallium arsenide. Toxicol. Appl. Pharmacol., 1984, 76(1), 96-104. (Pubitemid 14008954)
36. Webb, D.R.; Wilson, S.E. & Carter, D.E. Comparative pulmonary toxicity of gallium arsenide, gallium(III) oxide or arsenic(III) oxide intratracheally instilled into rats. Toxicol. Appl. Pharmacol., 1986, 82(3), 405-16. (Pubitemid 16162412)
37. NTP, 2000. Toxicology and carcinogenicity studies of gallium arsenide in F344/n rats and B6C3F1 mice (inhalation studies). Department of Health and Human Services, Public Health Services, Bethesda, MD, USA.
38. Ozaki, K.; Haseman, J. K.; Hailey, J. R.; Maranpot, R.R. & Nyska, A. Association of adrenal pheochromocytoma and lug pathology in inhalation studies with particulate compounds in the male F344 rat. Natl. Toxicol. Program Exp. Toxicol Pathol., 2002, 30(2), 263-327.
39. Omura, M.; Tanaka, A.; Zhao, M.; Hirata, M.; Makita, Y.; Inoue, N. & Gotoh, K. Toxic effects of gallium arsenide on sperm in rats by repeated intratracheal instillations. J. Occup. Health, 1995, 37(3), 165-66.
40. Flora, S.J. S. Alterations in some hepatic biochemical variables following repeated GaAs administration in rats. Int. Hepatol. Comm., 1996, 5(2), 97-103. (Pubitemid 26183617)
41. Lewis, T.A.; Hartmann, C.B. & McCoy, K.L. Gallium arsenide modulates proteolytic cathepsin activities and antigen processing by macrophages. Journal of Immunology, 1998, 161(5), 2151-157. (Pubitemid 28397024)
42. Harrison, M.T. & McCoy, K.L. Immunosuppression by arsenic: A comparison of cathepsin L inhibition and apoptosis. International Immunopharmacology, 2001, 1(4), 647-56. (Pubitemid 32206526)
43. Becker, S.M. & McCoy, K.L. Gallium arsenide selectivity up regulates inflammatory cytokine expression at exposure at exposure site. J. Pharmacol. Exp. Ther., 2003, 307, 1045-053. (Pubitemid 37494224)
44. Carter, D.E.; Aposhian, H.V. & Gandolfi, A.J. The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: A toxicochemical review. Toxicol. Appl. Pharmacol., 2003, 193(3), 309-34. (Pubitemid 37543540)
45. Rosner, M.H. & Carter, D.E. Metabolism and excretion of gallium arsenide and arsenic oxides by hamsters following intratracheally instillation. Fund. Appl. Toxicol., 1987, 9(4), 730-737. (Pubitemid 17165013)
46. Aizawa, Y.; Takata, T.; Magnetometric evaluation of the effects of gallium arsenide on the clearance and relaxation of iron particles. Ind. Health., 1993, 31(4), 143-53. (Pubitemid 24115263)
47. Bhatt, K.; Mittal, M.; Kaul, R.K.; Bhagyawant, S. & Flora, S. Beneficial role of zinc and iron co-administration during gallium arsenide exposure in rats. Curr. Trend. Biotechnol. Pharmacol., 2008, 2(), 228-36.
48. Van Amsterdam, J. A.; Kluin-Nelemans, J. C.; van Eck-Smit, B.L. & Pauwels, E.K. Role of 67Ga scintigraphy in localization of lymphoma. Ann. Hematol., 1996, 72(4), 202-07.
49. Salloum, E.; Brandt, D.S.; Caride, V.J. ; Cornelius, E.; Zelterman, J. S. D.; Schubert, W.; Mannino, T. & Cooper, D.L. Gallium scans in the management of patients with Hodgkin's disease: A study of 101 patients. J. Clin. Oncol., 1997, 15(2), 518-27. (Pubitemid 27074218)
50. Lopci, E.; Nanni, C.; Rampin, L.; Rubello, D. & Fanti, S. Clinical applications of 68Ga-DOTANOC in neuroendocrine tumours. Minerva Endocrinol., 2008, 33(3), 277-81.
51. Chitambar, C.R. Medical applications and toxicities of gallium compounds. Int. J. Environ. Res. Public. Health, 2010, 7(5), 2337-361.
52. Warrell, R.P.; Lovett, D.; Dilmanian, F.A.; Schneider, R. & Heelan, R.T. Low-dose gallium nitrate for prevention of osteolysis in myeloma: Results of a pilot randomized study. J. Clin. Oncol., 1993, 11(12), 2443-450. (Pubitemid 23353976)
53. Soignet, S.L.; Frankel, S.R.; Douer, D.; Tallman, M.S.; Kantarjian, H.; Calleja, E.; Stone, R.M.; Kalaycio, M.; Scheinberg, D.A.; Steinherz, P.; Sievers, E.L.; Coutre, S.; Dahlberg, S.; Ellison, R. & Warrell, R.P. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J. Clin. Oncol., 2001, 19(18), 3852-860. (Pubitemid 32880064)
54. Lu, J. ; Chew, E.H. & Holmgren, A. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc. Natl. Acad. Sci., 2007, 104(30), 12288-2293. (Pubitemid 47206130)
55. Flora, S.J. S. & Sekhar, K. Chronic Arsenic Poisoning: Target Organ Toxicity, Diagnosis and Treatment. In Pharmacological Perspectives of Some Toxic Chemicals and their Antidotes, edited by S.J. S. Flora; J. A. Romano; S.I. Baskin, & K. Sekhar. Narosa Publishing House, New Delhi, India, 2004, pp. 271-302.
56. Chitambar, C.R. & Seligman, P.A. Effects of different transferrin forms on transferrin receptor expression, iron uptake and cellular proliferation on human leukemic HL60 cells. J. Clin. Invest., 1986, 78(6), 1538-546.
57. Chitambar, C.R.; Wereley, J. P. & Matsuyama, S. Gallium-induced cell death in lymphoma: Role of transferrin receptor cycling, involvement of Bax and the mitochondria, and effects of proteasome inhibition. Mol. Cancer. Ther., 2006, 5, 2834-843. (Pubitemid 44849010)
58. Chitambar, C.R.; Purpi, D.P.; Woodliff, J. ; Y ang, M. & Wereley, J. P. Development of gallium compounds for treatment of lymphoma: Gallium maltolate, a novel hydroxypyrone gallium compound, induces apoptosis and circumvents lymphoma cell resistance to gallium nitrate. J. Pharmacol. Exp. Ther., 2007, 322(3), 1228-236. (Pubitemid 47295794)
59. Chang, K.L.; Liao, W.T.; Y u, C.L.; Lan, C.C.E.; Chang, L.W. & Y ue, H.S. Effects of gallium on immune stimulation and apoptosis induction in human peripheral blood mononuclear cells. Toxicol. Appl. Pharmacol., 2003, 193(2), 209-17. (Pubitemid 37476436)
60. Weinberg, G.A. Question from the clinician: Phages in infections. Pediatr. Rev., 2002, 23(9), 329-330.
61. Rocha, J. B.T.; Tuerlinckx, S.M.; Schetinger, M.R.C. & Folmer, V. Effect of Group 13 metals on porphobilinogen synthase in vitro. Toxicol. Appl. Pharmacol., 2004, 200(3), 169-76. (Pubitemid 39422416)
62. Monteiro, H.P. & Winterboune, C.C. The superoxide dependent transfer of iron from ferritin to transferrin and lactoferrin. Biochem. J., 1988, 256(3), 923-28. (Pubitemid 19021723)
63. Delnomdedieu, M.; Basti, M.M.; Styblo, M.; Otvos, J. D. & Thomas, D.J. Complexation of arsenic species in rabbit erythrocytes. Chem. Res. Toxicol., 1994, 7(5), 621-27. (Pubitemid 24302157)
64. Aposhian, H.V. Biochemical toxicology of arsenic. Rev. Biochem. Toxicol., 1989, 10, 265-99.
65. Flora, S.J. S.; Bhadauria, S.; Pant, S.C. & Dhakad R.K. Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats. Life Sci., 2005, 77(18), 2324-337. (Pubitemid 41169966)
66. Kitchin, K.T. Recent advances in arsenic carcinogenesis: Mode of action, animal model system and methylated arsenic metabolites. Toxicol. Appl. Pharmacol., 2001, 172(3), 249-61. (Pubitemid 32406033)
67. Mishra, D.; Mehta, A. & Flora, S.J. S. Reversal of arsenic induced hepatic apoptosis with combined administration DMSA and its analogue in Guinea pig: Role of glutathione and linked enzymes. Chem. Res. Toxicol., 2007, 21(2), 400-07.
68. Valko, M.; Rhodes, C.J. ; Moncol, J. ; Izakovic, M. & Mazur, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact., 2006, 160(1), 1-40. (Pubitemid 43227479)
69. Li, C.Y. & Jackson, R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell Physiol., 2002, 282(2), 227-41.
70. Ahmad, S.A.; Sayed, M.H.S.U.; Barua, S.; Khan, M.H.; Faruquee, M.H.; Jalil, A.; Haldi, S.A. & Talukder H.K. Arsenic in drinking water and pregnancy outcomes. Environ. Health. Perspect., 2001, 109(6), 629-31. (Pubitemid 32998776)
71. Squibb, K.S. & Fowler, B.A. The toxicity of arsenic and its compounds. In Biological and Environmental Effects of Arsenic, edited by Fowler B.A. Elsevier, New Y ork, 1983. pp. 233-69.
72. Kasai, H. Chemistry-based studies on oxidative DNA damage: Formation, repair, and mutagenesis. Free Rad. Biol. Med., 2002, 33(4), 450-56. (Pubitemid 34874966)
73. Yager, J. W. & Wiencke, J. K. Inhibition of poly (ADPribose) polymerase by arsenite. Mutation Res., 1997, 386(3), 345-51. (Pubitemid 27291534)
74. Counts, J. L. & Goodman, J. I. Hypomethylation of DNA: A nongenetoxic mechanism involved in tumor promotion. Toxicology Letters, 1995, 83(), 663-72. (Pubitemid 26054754)
75. Levander, O.A. Metabolic interrelationship between arsenic and selenium. Environ. Health Perspect., 1977, 19, 159-64.
76. Levander, O.A. & Baumann, C.A. Selenium metabolism. VI: Effect of arsenic on the excretion of selenium in the bile. Toxicol. Appl. Pharmacol., 1966, 9(1), 106-15.
77. Ferm, V.H. Arsenic as a teratogenic agent. Environ Health Perspect., 1998, 106, 203-16.
78. Glattre, E.; Mravcova, A.; Lener, J. ; Vobecky, M.; Egretova, E. & Mysliveckova, M. Study of distribution and interaction of arsenic and selenium in rat thyroid. Biol. Trace Elem. Res., 1995, 49(2-3), 177-86.
79. Flora, S.J. S. & Kumar, P. Biochemical and immunotoxicological alterations following repeated gallium arsenide exposure and their recoveries by meso-2, 3-dimercaptosuccinic acid and 2, 3-dimercaptopropane 1-sufonate administration in rats. Environ. Toxicol. Pharmacol., 1996, 2, 315-320. (Pubitemid 27008061)
80. Flora, S.J. S.; Bhattacharya, R. & Vijayaraghavan, R. Combined therapeutic potential of meso 2, 3-dimercaptosuccinic acid and calcium disodium edentate in the mobilization and distribution of lead in experimental lead intoxication in rats. Fundam. Appl. Toxicol., 2005, 25(2), 233-40.
81. Domingo, J. L.; Llobet, J. M. & Corbella, J. Relative efficacy of chelating agents as antidotes for acute gallium nitrate intoxication. Arch. Toxicol., 1987, 59(5), 382-83.
82. Flora, S.J. S.; Bhatt, K.; Dwivedi, N.; Pachauri, V. & Kushwah, P.K. Co-administration of meso 2, 3-dimercaptosuccinic acid monoesters reduces arsenic concentration and oxidative stress in gallium arsenide exposed rats. Clin. Exp. Pharmacol. Physiol., 2011, 38(7), 423-29.
83. Mevander, O.A. Letabolic interrelationship between arsenic and selenium. Environ. Health Perspect., 1977, 19, 159-64.